CONMED : Investor Presentation Q1 2025
CNMD
Published on 04/30/2025 at 17:37
Investor Presentation
Q1 2025 EȒnings
Pat J. Beyer
PíssidsnL »nd Ckisr ExscuLivs Orricsí
Todd W. Garner
ExscuLivs Vics PíssidsnL »nd Ckisr Fin»nci»l Orricsí
6píil 30, 2025
CONMED Vision
Empower healthcare providers worldwide to deliver exceptional outcomes for patients.
Focus bskind Lks Vision Psopls, PíoducLs, PíoriL»biliLy
Objectives for Our Shareholders
6ggísg»Ls gíowLk »nd píoriL»biliLy ovsí Lks long Lsím Lo signiric»nLly incís»ss Lks v»lu»Lion or Lks comp»ny
Evolvs píoducL mix Low»íd kigksí-gíowLk, kigksí-m»ígin orrsíings
Incís»ss ouí m»íksL sk»ís in l»ígs »nd »LLí»cLivs m»íksLs
Dslivsí »bovs-m»íksL ísvsnus »nd píoriL»biliLy gíowLk ovsí Lks long Lsím
Q1 2025 E»ínings C»ll 4
Orthopedics: Large, Attractive Markets
Sports Medicine & Biologics
Compísksnsivs poíLrolio or dsvicss roí ísp»ií »nd ks»ling or sorL Lissus injuíiss, including impl»nLs, biologics,
»llogí»rL Lissus, sn»bling dsvicss »nd ísl»Lsd insLíumsnLs
$5.1 to $5.3 Billion
6íLkísx Zimmsí ÞiomsL
DsPuy MiLsk 6llosouícs (J&J) LirsNsL
SmiLk & Nspksw RTI
SLíyksí
~$52M
Capital Equipment
Suígic»l díills/s»ws, kigk-dsriniLion suígic»l visu»liz»Lion sysLsms, »nd ísl»Lsd singls-uss »ccsssoíiss
$3.3 to $3.7 Billion
SLíyksí 6íLkísx
DsPuy SynLkss Olympus
(J&J) RickȒd Wolr
Zimmsí ÞiomsL K»íl SLoíz
SmiLk & Nspksw MsdLíonic (Mid»s
Rsx/ Xomsd)
~$35M
Foot & Ankle
Compísksnsivs poíLrolio includss impl»nLs, rí»cLuís sysLsms, biologics,
»nd ísl»Lsd k»ídw»ís
$4.8 to $5.0 Billion
SLíyksí Tís»cs
DsPuy SynLkss P»í»gon 28 (J&J) (Zimmsí ÞiomsL)
6íLkísx
~$49M
Total Orthopedics
60% to 70% in Surgery Centers in the U.S.
~$136M
~10% growth for total company
Dollar Value of 1 Market
Mar 2025 YTD
US
38%
International 62%
79%
Recurring, single-use revenue
Category Description Market Size and Competitors
Share Point
General Surgery: Large, Attractive Markets
Dollar Value of 1 Market
Access
6 pl»Lroím or dsvicss »nd »ccsssoíiss Lo cís»Ls »nd snLsí Lks suígic»l woíking sp»cs in minim»lly inv»sivs píocsduíss
$1.5 to $1.7 Billion
ELkicon (J&J) MsdLíonic
6pplisd Msdic»l Olympus
SLíyksí K»íl SLoíz
~$16M
Energy
RF snsígy Lo »rrscL Lissus by cuLLing, ss»ling, oí c»using ksmosL»sis in opsn oí minim»lly inv»sivs píocsduíss.
Smoks sv»cu»Lion »nd rilLí»Lion Lo suppoíL Lks suígic»l snviíonmsnL
$3.1 to $3.3 Billion
MsdLíonic SLíyksí
ELkicon (J&J) Coopsí Suígic»l
Olympus ERÞE
~$32M
Instruments
InsLíumsnLs »nd »ccsssoíiss roí minim»lly inv»sivs l»p»íoscopic, opsn,
»nd íoboLic »ppío»ckss
$1.6 to $1.8 Billion
K»íl SLoíz
6sscul»p
SLíyksí
~$17M
Endoscopic Technologies
Tksí»psuLic »nd di»gnosLic sndoscopic píoducLs ussd by G»sLíosnLsíologisLs
$3.1 to $3.3 Billion
ÞosLon ScisnLiric Olympus
Cook Msdic»l MsíiL EndoLsk
C»nLsl STERIS
~$32M
Critical Care
Singls-uss dsvicss roí moniLoíing c»ídi»c »cLiviLy »nd oLksí p»LisnL c»ís dsvicss
$0.8 to $1.0 Billion
3M Comp»ny
C»ídin»l
~$9M
Total General Surgery
90% to 95% in Hospitals
~$106M
~8% growth for total company
Category Description Market Size and Competitors
Share Point
Mar 2025 YTD
International
29%
US 71%
92%
Recurring, single-use revenue
Disclaimer
CONMED Corporation published this content on April 30, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 30, 2025 at 21:36 UTC.